C198H248N20O11S — CID 160627808
6-tert-butyl-1H-benzimidazole;7-tert-butyl-4H-1,4-benzothiazin-3-one;2-tert-butyl-3,4-dihydro-1H-isoquinoline;6-tert-butyl-3,4-dihydro-2H-isoquinolin-1-one;7-tert-butyl-3,4-dihydro-2H-isoquinolin-1-one;6-tert-butyl-2,3-dihydrophthalazine-1,4-dione;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-3,4-dihydro-1H-quinolin-2-one;5-tert-butyl-1H-indazole;6-tert-butyl-1H-indazole;5-tert-butyl-1H-indole;6-tert-butyl-1H-indole;6-tert-butyl-2H-isoquinolin-1-one;7-tert-butyl-2H-isoquinolin-1-one;6-tert-butyl-1H-quinolin-2-one;7-tert-butyl-1H-quinolin-2-one (PubChem CID 160627808) has the molecular formula C198H248N20O11S and a molecular weight of 3116.36 g/mol. Its IUPAC name is 6-tert-butyl-1H-benzimidazole;7-tert-butyl-4H-1,4-benzothiazin-3-one;2-tert-butyl-3,4-dihydro-1H-isoquinoline;6-tert-butyl-3,4-dihydro-2H-isoquinolin-1-one;7-tert-butyl-3,4-dihydro-2H-isoquinolin-1-one;6-tert-butyl-2,3-dihydrophthalazine-1,4-dione;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-3,4-dihydro-1H-quinolin-2-one;5-tert-butyl-1H-indazole;6-tert-butyl-1H-indazole;5-tert-butyl-1H-indole;6-tert-butyl-1H-indole;6-tert-butyl-2H-isoquinolin-1-one;7-tert-butyl-2H-isoquinolin-1-one;6-tert-butyl-1H-quinolin-2-one;7-tert-butyl-1H-quinolin-2-one.
| Compound Name | 6-tert-butyl-1H-benzimidazole;7-tert-butyl-4H-1,4-benzothiazin-3-one;2-tert-butyl-3,4-dihydro-1H-isoquinoline;6-tert-butyl-3,4-dihydro-2H-isoquinolin-1-one;7-tert-butyl-3,4-dihydro-2H-isoquinolin-1-one;6-tert-butyl-2,3-dihydrophthalazine-1,4-dione;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-3,4-dihydro-1H-quinolin-2-one;5-tert-butyl-1H-indazole;6-tert-butyl-1H-indazole;5-tert-butyl-1H-indole;6-tert-butyl-1H-indole;6-tert-butyl-2H-isoquinolin-1-one;7-tert-butyl-2H-isoquinolin-1-one;6-tert-butyl-1H-quinolin-2-one;7-tert-butyl-1H-quinolin-2-one |
|---|---|
| PubChem CID | 160627808 |
| Molecular Formula | C198H248N20O11S |
| Molecular Weight | 3116.36 g/mol |
| Exact Mass | 3113.92 |
| IUPAC Name | 6-tert-butyl-1H-benzimidazole;7-tert-butyl-4H-1,4-benzothiazin-3-one;2-tert-butyl-3,4-dihydro-1H-isoquinoline;6-tert-butyl-3,4-dihydro-2H-isoquinolin-1-one;7-tert-butyl-3,4-dihydro-2H-isoquinolin-1-one;6-tert-butyl-2,3-dihydrophthalazine-1,4-dione;6-tert-butyl-3,4-dihydro-1H-quinolin-2-one;7-tert-butyl-3,4-dihydro-1H-quinolin-2-one;5-tert-butyl-1H-indazole;6-tert-butyl-1H-indazole;5-tert-butyl-1H-indole;6-tert-butyl-1H-indole;6-tert-butyl-2H-isoquinolin-1-one;7-tert-butyl-2H-isoquinolin-1-one;6-tert-butyl-1H-quinolin-2-one;7-tert-butyl-1H-quinolin-2-one |
| SMILES | CC(C)(C)N1CCc2ccccc2C1.CC(C)(C)c1ccc2[nH]c(=O)ccc2c1.CC(C)(C)c1ccc2[nH]ccc2c1.CC(C)(C)c1ccc2[nH]ncc2c1.CC(C)(C)c1ccc2c(=O)[nH][nH]c(=O)c2c1.CC(C)(C)c1ccc2c(=O)[nH]ccc2c1.CC(C)(C)c1ccc2c(c1)C(=O)NCC2.CC(C)(C)c1ccc2c(c1)CCC(=O)N2.CC(C)(C)c1ccc2c(c1)CCNC2=O.CC(C)(C)c1ccc2c(c1)NC(=O)CC2.CC(C)(C)c1ccc2c(c1)SCC(=O)N2.CC(C)(C)c1ccc2cc[nH]c(=O)c2c1.CC(C)(C)c1ccc2cc[nH]c2c1.CC(C)(C)c1ccc2ccc(=O)[nH]c2c1.CC(C)(C)c1ccc2cn[nH]c2c1.CC(C)(C)c1ccc2nc[nH]c2c1 |
| InChI | InChI=1S/C13H17NO.C13H15NO.C13H17NO.C13H15NO.C13H17NO.C13H15NO.C13H17NO.C13H15NO.C13H19N.C12H14N2O2.C12H15NOS.2C12H15N.3C11H14N2/c2*1-13(2,3)10-5-6-11-9(8-10)4-7-12(15)14-11;2*1-13(2,3)10-6-4-9-5-7-12(15)14-11(9)8-10;2*1-13(2,3)10-4-5-11-9(8-10)6-7-14-12(11)15;2*1-13(2,3)10-5-4-9-6-7-14-12(15)11(9)8-10;1-13(2,3)14-9-8-11-6-4-5-7-12(11)10-14;1-12(2,3)7-4-5-8-9(6-7)11(16)14-13-10(8)15;1-12(2,3)8-4-5-9-10(6-8)15-7-11(14)13-9;1-12(2,3)10-4-5-11-9(8-10)6-7-13-11;1-12(2,3)10-5-4-9-6-7-13-11(9)8-10;1-11(2,3)9-4-5-10-8(6-9)7-12-13-10;1-11(2,3)9-5-4-8-7-12-13-10(8)6-9;1-11(2,3)8-4-5-9-10(6-8)13-7-12-9/h5-6,8H,4,7H2,1-3H3,(H,14,15);4-8H,1-3H3,(H,14,15);4,6,8H,5,7H2,1-3H3,(H,14,15);4-8H,1-3H3,(H,14,15);4-5,8H,6-7H2,1-3H3,(H,14,15);4-8H,1-3H3,(H,14,15);4-5,8H,6-7H2,1-3H3,(H,14,15);4-8H,1-3H3,(H,14,15);4-7H,8-10H2,1-3H3;4-6H,1-3H3,(H,13,15)(H,14,16);4-6H,7H2,1-3H3,(H,13,14);2*4-8,13H,1-3H3;3*4-7H,1-3H3,(H,12,13) |
| InChIKey | RHNNGUVBYAAZEO-UHFFFAOYSA-N |
| XLogP | 44.48 |
| TPSA | 463.52 Ų |
| H-Bond Donors | 16 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | |
| Heavy Atoms | 230 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3116.36 |
| LogP ≤ 5 | 44.48 |
| H-Bond Donors ≤ 5 | 16 |
| H-Bond Acceptors ≤ 10 | 16 |